ArticlePharmaceutics2025

The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience Program.

Stephen B Hanauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.